January 18, 2017

Access Accelerated Initiative – coming together to tackle NCDs

On Wednesday, January 18, 2017, during the World Economic Forum in Davos, Switzerland, Sanofi together with 21 of our industry competitors and peers, the World Bank and the Union for International Cancer Control (UICC) launched the Access Accelerated Initiative (AAI)— a new coalition to address the burden of non-communicable diseases (NCDs) in low and lower-middle income countries.

NCDs have emerged as a major public health threat over the last few decades and are now at a point of crisis. It is estimated that NCDs – including cancers, cardiovascular diseases, chronic respiratory diseases, diabetes and mental health disorders – are responsible for as many as 36 million deaths each year. According to the World Health Organization1, almost three-quarters of NCD-related deaths occur in low- and middle-income countries, where access to healthcare is limited.

>> Read the article

 







>> Watch the video of Olivier Brandicourt, CEO Sanofi

 

Access Accelerated Initiative – coming together to tackle NCDs
On Wednesday, January 18, 2017, during the World Economic Forum in Davos, Switzerland, Sanofi together with 21 of our industry competitors and peers, the World Bank and the Union for International Cancer Control (UICC) launched the Access Accelerated Initiative (AAI)— a new coalition to address the burden of non-communicable diseases (NCDs) in low and lower-middle income countries.

NCDs have emerged as a major public health threat over the last few decades and are now at a point of crisis. It is estimated that NCDs – including cancers, cardiovascular diseases, chronic respiratory diseases, diabetes and mental health disorders – are responsible for as many as 36 million deaths each year. According to the World Health Organization1, almost three-quarters of NCD-related deaths occur in low- and middle-income countries, where access to healthcare is limited.

>> Read the article

 







>> Watch the video of Olivier Brandicourt, CEO Sanofi